These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31759018)

  • 1. Chitosan coated liposomes (CCL) containing triamcinolone acetonide for sustained delivery: A potential topical treatment for posterior segment diseases.
    Khalil M; Hashmi U; Riaz R; Rukh Abbas S
    Int J Biol Macromol; 2020 Jan; 143():483-491. PubMed ID: 31759018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
    Cheng T; Li J; Cheng Y; Zhang X; Qu Y
    Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation.
    Huang C; Li C; Muhemaitia P
    Libyan J Med; 2019 Dec; 14(1):1548252. PubMed ID: 30460877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterisation of a novel chitosan-coated antioxidant liposome containing both coenzyme Q10 and alpha-lipoic acid.
    Zhao GD; Sun R; Ni SL; Xia Q
    J Microencapsul; 2015; 32(2):157-65. PubMed ID: 25329530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye.
    Li J; Cheng T; Tian Q; Cheng Y; Zhao L; Zhang X; Qu Y
    Drug Deliv; 2019 Dec; 26(1):188-198. PubMed ID: 30835587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation.
    Raval N; Khunt D; Misra M
    J Microencapsul; 2018 Jan; 35(1):62-77. PubMed ID: 29307286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization.
    Mu H; Wang Y; Chu Y; Jiang Y; Hua H; Chu L; Wang K; Wang A; Liu W; Li Y; Fu F; Sun K
    Drug Deliv; 2018 Nov; 25(1):1372-1383. PubMed ID: 29869520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization.
    Tavakoli S; Puranen J; Bahrpeyma S; Lautala VE; Karumo S; Lajunen T; Del Amo EM; Ruponen M; Urtti A
    Int J Pharm; 2022 May; 620():121725. PubMed ID: 35405282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery.
    Dandamudi M; McLoughlin P; Behl G; Rani S; Coffey L; Chauhan A; Kent D; Fitzhenry L
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
    Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization.
    Tatar O; Adam A; Shinoda K; Kaiserling E; Boeyden V; Claes C; Eckardt C; Eckert T; Pertile G; Scharioth GB; Yoeruek E; Szurman P; Bartz-Schmidt KU; Grisanti S
    Arch Ophthalmol; 2009 Mar; 127(3):275-81. PubMed ID: 19273790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
    He W; Guo X; Feng M; Mao N
    Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery.
    Jain AK; Chalasani KB; Khar RK; Ahmed FJ; Diwan PV
    J Drug Target; 2007 Jul; 15(6):417-27. PubMed ID: 17613660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Nozaki M; Ogura Y
    Retina; 2005 Jun; 25(4):503-9. PubMed ID: 15933599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate.
    Suarez S; Gonzalez-Rothi RJ; Schreier H; Hochhaus G
    Pharm Res; 1998 Mar; 15(3):461-5. PubMed ID: 9563078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical studies on chitosan-coated liposomes.
    Mady MM; Darwish MM; Khalil S; Khalil WM
    Eur Biophys J; 2009 Oct; 38(8):1127-33. PubMed ID: 19649627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes.
    Haeri A; Sadeghian S; Rabbani S; Anvari MS; Ghassemi S; Radfar F; Dadashzadeh S
    Carbohydr Polym; 2017 Feb; 157():1461-1469. PubMed ID: 27987857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.